Andrew Nat
Verified
Over 15 years of venture capital, private equity and early stage company experience. Closed over $66 million in early stage life science company investments. Two of these companies have had successful IPOs and a third is currently pricing its IPO. One of these companies, ZS Pharma has received a $2.5 billion offer from a major drug company.
I also have extensive energy background. Closed over $2.6 billion in transactions over the course of my career.